Mínimo 3 entidades de 3 países
While medicinal products contribute considerably to the health of EU citizens, they can also have adverse reactions. It is estimated that around 5% of all hospital deaths are due to an adverse drug reaction. ) accounting for most ADRs. Overall, ADRs increase morbidity, mortality, hospitalisations, and healthcare costs.
Ver en el portal de la ComisiónFuente:Portal Funding & Tenders (Comisión Europea), actualizado el 29 oct 2026